Literature DB >> 6260672

Complement requirement for virus neutralization by antibody and reduced serum complement levels associated with experimental equine herpesvirus 1 infection.

D B Snyder, A C Myrup, S K Dutta.   

Abstract

Pony foals, negative for detectable serum-neutralizing antibody to equine herpesvirus 1 by the standard tube-culture virus neutralization test, were experimentally infected with equine herpesvirus 1. Complement-requiring (CR) and non-complement-requiring (NCR) serum-neutralizing antibodies were evaluated in preinfection and postinfection sera by means of a complement-enhanced plaque reduction assay. Low levels of CR antibodies were found in the preinfection sera of only group II ponies. Upon infection, CR antibodies were detected by day 2 postinfection and reached peak titers between 7 and 14 days postinfection in the antisera of all ponies. NCR antibodies were detected later than CR antibodies and at levels approximately 40 to 150 times lower than the latter. CR/NCR ratios indicated that complement requirement was greatest early in the acute stages of disease and that this requirement decreased during the convalescent phase. Fractionation of 1-week and 2-week postinfection antisera of group I ponies indicated the CR antibody activity resided in both the 7S and 19S fractions. Total serum complement levels of the ponies were quantified throughout the infection with an equine anti-goat erythrocyte hemolytic system. In vivo, complement levels were depressed for all ponies during the first 2 weeks of infection. A decline in complement levels was seen as early as day 2, and they decreased to an average of 35% of preinfection levels on day 10 postinfection for all ponies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260672      PMCID: PMC351356          DOI: 10.1128/iai.31.2.636-640.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Complement requirement of neutralizing antibodies in different classes of immunoglobulin appearing in rabbits and guinea pigs after primary and booster immunizations with herpes simplex virus.

Authors:  K Shinkai; K Yoshino
Journal:  Jpn J Microbiol       Date:  1975-02

2.  Formation and biologic role of polyoma virus-antibody complexes. A critical role for complement.

Authors:  M B Oldstone; N R Cooper; D L Larson
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

3.  Studies on the neutralization of herpes simplex virus. VI. The mode of action of complement upon antibodysensitized virus.

Authors:  K Yoshino; T Kishie
Journal:  Jpn J Microbiol       Date:  1973-01

4.  Complement-requiring neutralizing antibodies in hyperimmune sera to human cytomegaloviruses.

Authors:  B J Graham; Y Minamishima; G R Dresman; H G Haines; M Benyesh-Melnick
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  Complement-requiring neutralizing antibodies in cattle to infectious bovine rhinotracheitis virus.

Authors:  C R Rossi; G K Kiesel
Journal:  Arch Gesamte Virusforsch       Date:  1974

6.  Herpes simplex neutralizing antibody--quantitation of the complement-dependent fraction in different phases of adult human infection.

Authors:  H S Heineman
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

7.  The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.

Authors:  V A Bokisch; F H Top; P K Russell; F J Dixon; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

8.  The complement-requiring neutralization of equine arteritis virus by late antisera.

Authors:  A I Radwan; D Burger
Journal:  Virology       Date:  1973-01       Impact factor: 3.616

9.  Acute viral infection: tissue injury mediated by anti-viral antibody through a complement effector system.

Authors:  M B Oldstone; F J Dixon
Journal:  J Immunol       Date:  1971-11       Impact factor: 5.422

10.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

View more
  7 in total

1.  Infectious center assay of intracellular virus and infective virus titer for equine mononuclear cells infected in vivo and in vitro with equine herpesviruses.

Authors:  S K Dutta; A C Myrup
Journal:  Can J Comp Med       Date:  1983-01

Review 2.  The complement system: its importance in the host response to viral infection.

Authors:  R L Hirsch
Journal:  Microbiol Rev       Date:  1982-03

3.  Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

Authors:  G R Nemerow; F C Jensen; N R Cooper
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

4.  Neutralizing antibody response of rabbits and goats to caprine arthritis-encephalitis virus.

Authors:  P Klevjer-Anderson; T C McGuire
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

5.  Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism.

Authors:  Erin Mehlhop; Anja Fuchs; Michael Engle; Michael S Diamond
Journal:  Virology       Date:  2009-09-09       Impact factor: 3.616

Review 6.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

7.  The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.

Authors:  Melanie J Lewis; Bettina Wagner; Jenny M Woof
Journal:  Mol Immunol       Date:  2007-07-31       Impact factor: 4.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.